+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Automated Immunoassay Analyzers Market - By Sales Model, By End-User, and By Region - Global Industry Perspective, Comprehensive Analysis, and Forecast, 2020 - 2026

  • ID: 5143382
  • Report
  • July 2020
  • Region: Global
  • Zion Market Research
The global Automated Immunoassay Analyzers Market, which accrued earnings worth 11.02 (USD Billion) in 2019, is projected to record the CAGR of more than 16.1% over the period from 2020 to 2026. The report offers assessment and analysis of the Automated Immunoassay Analyzers market on a global and regional level. The study offers a comprehensive assessment of the market competition, constraints, sales estimates, opportunities, evolving trends, and industry-validated data. The report offers historical data from 2017 to 2019 along with a forecast from 2020 to 2026 based on revenue (USD Billion).

Introduction

Automated Immunoassay is a method that can be utilized for determining the existence of a specific substance in the human body. The substance can be in the form of either antigen, hormone, pathogen, enzyme, or antibody. Furthermore, immunoassay depends on the principle of antibody & antigen specificity. Apart from this, automated immunoassays are used extensively in clinical diagnostics, clinical chemistry, and for quality control in food & beverages, pharma, and biotech sectors.

Market Growth Dynamics

Rapidly surging old-age population prone to contagious ailment has resulted in conducting of large number of diagnostic tests. This has prompted the demand for automated immunoassay analyzers, thereby steering the market trends. In addition to this, preventive healthcare as well as lab automation and their integration are few of the aspects that will embellish the expansion of automated immunoassay analyzers industry over the forthcoming years.

Apparently, the escalating demand for global standardization and comparability of the outcomes will enhance the popularity of automated immunoassay analyzers in the years ahead. Additionally, the breakthroughs witnessed in the biotechnology and huge funding of research activities in the bio-chemistry, bio-medical, and pharma fields will augment the industry size during the forecast timeline. Moreover, rise in the occurrence of chronic ailments and pandemics like COVID-19 and improvement in healthcare amenities witnessed in developing nations will fuel the market elevation in the years to come.

North America To Contribute Remarkably Towards Overall Market Share By 2026

The regional market expansion during the forecast timeline is owing to humungous presence of major players in the sub-continent. Large-scale acceptance of innovative technologies in medicine across the countries like the U.S. and Canada will enhance the popularity of automated immunoassay analyzers in the region.

Key players influencing the market growth are Luminex Corporation, Biokit, Biomerieux, Siemens Healthcare, Abbott Diagnostics, and Roche Diagnostics.

The global automated immunoassay analyzers market is segmented as follows:

By Technology
  • Chemiluminescence Immunoassay (CLIA)
  • Enzyme-Linked Fluorescent Immunoassay (ELFA)
  • Enzyme-linked Immunosorbent Assay (ELISA)
  • Radioimmunoassay (RIA)
  • Others (Biochip Assay, Immunofluorescent Assay, and Counting Assay)
By Sales Model
  • Reagent Rental / Lease
  • Outright Sale
By End-User
  • Hospitals
  • Diagnostic Laboratories
  • Blood Banks
  • Others (Research Institutes, Pharmaceutical & Biotechnology Industry, Food & Beverages Industry)
By Region
  • North America
  • The U.S.
  • Canada
  • Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
  • Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa
Note: Product cover images may vary from those shown
  • Chapter 1. Preface
    • 1.1. Report Description and Scope
    • 1.2. Research Scope
    • 1.3. Research Methodology
      • 1.3.1. Market Research Process
      • 1.3.2. Market Research Methodology
  • Chapter 2. Executive Summary
    • 2.1. Automated Immunoassay Analyzers Market, 2016–2026(USD Billion)
    • 2.2. Automated Immunoassay Analyzers Market: Snapshot
  • Chapter 3. Global Automated Immunoassay Analyzers Market– Industry Analysis
    • 3.1. Automated Immunoassay Analyzers Market: Market Dynamics
    • 3.2. Market Drivers
      • 3.2.1. The breakthroughs witnessed in the biotechnology and huge funding of research activities in the bio-chemistry, bio-medical, and pharma fields will augment the business landscape.
      • 3.2.2. Rise in the occurrence of chronic ailments and pandemics like COVID-19 along with the improvement in healthcare amenities witnessed in emerging nations will propel the market elevation in the ensuing years.
    • 3.3. Porter’s Five Forces Analysis
    • 3.4. Market Attractiveness Analysis
      • 3.4.1. Market attractiveness analysis By technology
      • 3.4.2. Market attractiveness analysis By Sales Model
      • 3.4.3. Market attractiveness analysis By End-User
  • Chapter 4. Global Automated Immunoassay Analyzers Market– Competitive Landscape
    • 4.1. Company market share analysis
      • 4.1.1. Global Automated Immunoassay Analyzers Market: company market share, 2019
    • 4.2. Strategic development
      • 4.2.1. Acquisitions & mergers
      • 4.2.2. New Product launches
      • 4.2.3. Agreements, partnerships, collaborations, and joint ventures
      • 4.2.4. Research and development and Regional expansion
    • 4.3. Price trend analysis
  • Chapter 5. Global Automated Immunoassay Analyzers Market–technology Analysis
    • 5.1. Global Automated Immunoassay Analyzers Market overview: By technology
      • 5.1.1. Global Automated Immunoassay Analyzers Market share, By technology,2019 and 2026
    • 5.2. Enzyme-Linked Fluorescent Immunoassay (ELFA)
      • 5.2.1. Global Automated Immunoassay Analyzers Market by Enzyme-Linked Fluorescent Immunoassay (ELFA), 2016–2026(USD Billion)
    • 5.3. Chemiluminescence Immunoassay (CLIA)
      • 5.3.1. Global Automated Immunoassay Analyzers Market by Chemiluminescence Immunoassay (CLIA), 2016–2026(USD Billion)
    • 5.4. Radioimmunoassay (RIA)
      • 5.4.1. Global Automated Immunoassay Analyzers Market by Radioimmunoassay (RIA), 2016–2026(USD Billion)
    • 5.5. Enzyme-Linked Immunosorbent Assay (ELISA)
      • 5.5.1. Global Automated Immunoassay Analyzers Market by Enzyme-Linked Immunosorbent Assay (ELISA), 2016–2026(USD Billion)
  • Chapter 6. Global Automated Immunoassay Analyzers Market–Sales Model Analysis
    • 6.1. Global Automated Immunoassay Analyzers Market overview: By Sales Model
      • 6.1.1. Global Automated Immunoassay Analyzers Market share, By Sales Model , 2019 and 2026
    • 6.2. Outright Sale
      • 6.2.1. Global Automated Immunoassay Analyzers Market By Outright Sale , 2016–2026(USD Billion)
    • 6.3. Reagent Rental/Lease
      • 6.3.1. Global Automated Immunoassay Analyzers Market By Reagent Rental/Lease, 2016–2026(USD Billion)
  • Chapter 7. Global Cast Iron Cookware Market– End-User Analysis
    • 7.1. Global Cast Iron Cookware Market overview: By End-User
      • 7.1.1. Global Cast Iron Cookware Market share, By End-User , 2019 and 2026
    • 7.2. Diagnostic Laboratories
      • 7.2.1. Global Cast Iron Cookware Market By Diagnostic Laboratories, 2016–2026(USD Billion)
    • 7.3. Hospitals
      • 7.3.1. Global Cast Iron Cookware Market By Hospitals, 2016–2026(USD Billion)
    • 7.4. Blood Bank
      • 7.4.1. Global Cast Iron Cookware Market By Blood Bank, 2016–2026(USD Billion)
  • Chapter 8. Company Profiles
    • 8.1. Biokit
      • 8.1.1. Overview
      • 8.1.2. Financials
      • 8.1.3. Product Portfolio
      • 8.1.4. Business Strategy
      • 8.1.5. Recent Developments
    • 8.2. Siemens Healthcare
      • 8.2.1. Overview
      • 8.2.2. Financials
      • 8.2.3. Product Portfolio
      • 8.2.4. Business Strategy
      • 8.2.5. Recent Developments
    • 8.3. Abbott Diagnostics
      • 8.3.1. Overview
      • 8.3.2. Financials
      • 8.3.3. Product Portfolio
      • 8.3.4. Business Strategy
      • 8.3.5. Recent Developments
    • 8.4. Luminex Corporation
      • 8.4.1. Overview
      • 8.4.2. Financials
      • 8.4.3. Product Portfolio
      • 8.4.4. Business Strategy
      • 8.4.5. Recent Developments
    • 8.5. Biomerieux
      • 8.5.1. Overview
      • 8.5.2. Financials
      • 8.5.3. Product Portfolio
      • 8.5.4. Business Strategy
      • 8.5.5. Recent Development
    • 8.6. Roche Diagnostics
      • 8.6.1. Overview
      • 8.6.2. Financials
      • 8.6.3. Product Portfolio
      • 8.6.4. Business Strategy
      • 8.6.5. Recent Development
Note: Product cover images may vary from those shown
Adroll
adroll